Invenomic Fund (BIVRX)
The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio (greater than 80%), while allowing the size of the short portfolio to fluctuate based on the market opportunity. The fund may invest in equity securities of any type and across all market capitalizations. It may invest in securities of companies operating less than three years ("unseasoned issuers") and in initial public offerings of securities ("IPO").
Fund Info
US66538F4708
66538F470
Jun 18, 2017
$5,000
Mid-Cap
Value
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Invenomic Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Invenomic Fund had a return of -12.53% year-to-date (YTD) and -24.43% in the last 12 months.
BIVRX
-12.53%
1.20%
-5.11%
-24.43%
8.54%
N/A
^GSPC (Benchmark)
24.05%
1.08%
11.50%
30.38%
13.77%
11.13%
Monthly Returns
The table below presents the monthly returns of BIVRX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.69% | -7.39% | 3.79% | 0.44% | -1.16% | -5.35% | 2.65% | -0.11% | -2.13% | 0.29% | -12.53% | ||
| 2023 | 10.05% | -2.00% | 3.29% | 2.42% | -3.37% | -1.90% | 1.80% | 1.73% | 1.70% | 1.10% | 0.17% | -14.39% | -1.26% |
| 2022 | 20.00% | 4.11% | 3.06% | 6.89% | 6.61% | -7.07% | -1.02% | -0.04% | -3.82% | 5.63% | 6.26% | -20.34% | 16.00% |
| 2021 | 2.36% | 10.96% | 16.46% | 2.77% | 12.32% | -10.49% | 2.08% | -0.53% | 2.34% | -1.32% | 3.42% | -3.25% | 40.24% |
| 2020 | -5.96% | -6.06% | -3.17% | 9.02% | -3.66% | 1.17% | 0.10% | 1.35% | -2.85% | 3.52% | 15.60% | 0.57% | 7.80% |
| 2019 | 6.80% | -0.00% | -1.42% | 2.33% | -5.79% | 3.72% | -1.79% | -5.94% | 10.50% | 0.26% | 0.26% | -0.17% | 7.84% |
| 2018 | 3.36% | 0.72% | -1.61% | 1.00% | -2.35% | -0.09% | 0.09% | -1.48% | 2.25% | 1.01% | 2.99% | -6.78% | -1.31% |
| 2017 | 0.70% | 0.79% | -1.38% | 1.50% | 0.49% | 3.23% | 1.71% | 7.20% |
Expense Ratio
BIVRX has a high expense ratio of 2.48%, indicating higher-than-average management fees.
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of BIVRX is 0, indicating that it is in the bottom 0% of mutual funds on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Invenomic Fund (BIVRX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Invenomic Fund provided a 3.00% dividend yield over the last twelve months, with an annual payout of $0.51 per share.
| Period | TTM | 2023 |
|---|---|---|
| Dividend | $0.51 | $0.51 |
Dividend yield | 3.00% | 2.62% |
Monthly Dividends
The table displays the monthly dividend distributions for Invenomic Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| 2023 | $0.51 | $0.51 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Invenomic Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Invenomic Fund was 34.31%, occurring on Oct 14, 2024. The portfolio has not yet recovered.
The current Invenomic Fund drawdown is 32.88%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -34.31% | Jun 9, 2022 | 590 | Oct 14, 2024 | — | — | — |
| -20.86% | Nov 6, 2019 | 91 | Mar 18, 2020 | 165 | Nov 10, 2020 | 256 |
| -16.57% | May 18, 2021 | 88 | Sep 21, 2021 | 81 | Jan 14, 2022 | 169 |
| -13.23% | Dec 7, 2020 | 12 | Dec 22, 2020 | 40 | Feb 22, 2021 | 52 |
| -12.87% | Apr 22, 2019 | 90 | Aug 27, 2019 | 48 | Nov 4, 2019 | 138 |
Volatility
Volatility Chart
The current Invenomic Fund volatility is 3.01%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.